Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Equity Income (2022)

Arcadia Biosciences (RKDA) has disclosed Equity Income for 2 consecutive years, with $1.1 million as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Equity Income changed N/A year-over-year to $1.1 million, compared with a TTM value of $1.1 million through Dec 2023, changed 0.0%, and an annual FY2022 reading of $1.1 million, changed N/A over the prior year.
  • Equity Income was $1.1 million for Q2 2022 at Arcadia Biosciences, up from -$536000.0 in the prior quarter.
  • Across five years, Equity Income topped out at $1.1 million in Q2 2022 and bottomed at $1.1 million in Q2 2022.